FUAD EL RASSI: Open Payments
NPI 1174787352 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$24,455 in 26 payments from 6 companies in 2025. Trend: 2023 $14,781 · 2024 $4,080 · 2025 $24,455
Consulting: $20,415Travel & lodging: $3,492Honoraria: $300Food & beverage: $180Education: $68
| Company | Payments | Amount |
|---|---|---|
| Agios Pharmaceuticals, Inc. | 16 | $9,565 |
| PFIZER INC. | 2 | $8,450 |
| CSL Behring | 1 | $4,750 |
| E.R. Squibb & Sons, L.L.C. | 5 | $1,322 |
| Chiesi USA, Inc. | 1 | $300 |
| AstraZeneca Pharmaceuticals LP | 1 | $68 |
Products named: PYRUKYND, FERRIPROX, IMFINZI.
Industry payments across GA — which companies pay providers there.
